The effect of a single course of antenatal corticosteroids on maternal adrenal function at term

J Matern Fetal Neonatal Med. 2004 Jul;16(1):33-6. doi: 10.1080/14767050412331283102.

Abstract

Objective: To determine if one course of antenatal corticosteroids at 32 weeks produces maternal adrenal suppression at term.

Methods: The adrenocorticotropic hormone (ACTH) stimulation test was administered at 38 weeks to 11 pregnant women who had received a single course of antenatal betamethasone prior to 33 weeks and to six control subjects.

Results: There was no difference in basal cortisol levels (mean+/-standard deviation) between the two groups: 41.6+/-6.9 microg/dl for controls versus 36.0+/-7.8 microg/dl for the steroid group, p=0.16. Peak cortisol levels at 45 min following ACTH stimulation were not different: 61.6+/-3.5 microg/dl for controls versus 55.0+/-2.6 microg/dl for the steroid group, p=0.16. The power of the study to detect a statistical difference in the observed peak cortisol levels was greater than 95%. None of the study subjects had laboratory criteria or clinical signs of adrenal suppression.

Conclusions: A single course of betamethasone for women at risk for preterm delivery does not produce adrenal insufficiency at term and stress dose steroids are not recommended.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Cortex Function Tests
  • Adrenal Glands / drug effects*
  • Adrenocorticotropic Hormone / blood
  • Adult
  • Anti-Inflammatory Agents / administration & dosage*
  • Betamethasone / administration & dosage*
  • Cohort Studies
  • Female
  • Humans
  • Middle Aged
  • Pregnancy
  • Pregnancy, High-Risk
  • Prospective Studies
  • Statistics, Nonparametric
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Adrenocorticotropic Hormone
  • Betamethasone